Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Cytoxan, Epirubicin, and Capecitabine in Women With Stage I/II/IIIA Breast Cancer

NCT00146588 is registered in ClinicalTrials.gov with Craig A. Bunnell, MD, MPH as lead sponsor.

NCT NCT00146588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00146588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Cytoxan, Epirubicin, and Capecitabine in Women With Stage I/II/IIIA Breast Cancer
Lead sponsor
Craig A. Bunnell, MD, MPH
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2002
Completion date
December 31, 2004
Enrollment
55 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, stage i breast cancer, stage ii breast cancer, stage iiia breast cancer